ArticleHaematologica2026

Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group.

Kari Lenita Falck Moore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.